Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status
2014 ◽
Vol 99
(4)
◽
pp. 513-518
◽
2019 ◽
2019 ◽
2019 ◽
2020 ◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7018-7018
◽
2017 ◽
Vol 107
(6)
◽
pp. 712-715
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 7050-7050